123 related articles for article (PubMed ID: 16102728)
21. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
22. Transactivation of vimentin by beta-catenin in human breast cancer cells.
Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM
Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294
[TBL] [Abstract][Full Text] [Related]
23. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of beta-catenin/Tcf signaling by flavonoids.
Park S; Choi J
J Cell Biochem; 2010 Aug; 110(6):1376-85. PubMed ID: 20564233
[TBL] [Abstract][Full Text] [Related]
25. Galectin-3, a novel binding partner of beta-catenin.
Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-alpha: possible involvement of multiple signal transduction and beta-catenin/T-cell factor.
Lee EO; Shin YJ; Chong YH
J Neuroimmunol; 2004 Oct; 155(1-2):21-31. PubMed ID: 15342193
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of nordihydroguaiaretic acid on β-catenin/Tcf signalling in β-catenin-activated cells.
Park S; Lee J
Cell Biochem Funct; 2011; 29(1):22-9. PubMed ID: 21264886
[TBL] [Abstract][Full Text] [Related]
28. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
29. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
[TBL] [Abstract][Full Text] [Related]
31. Streptonigrin inhibits β-Catenin/Tcf signaling and shows cytotoxicity in β-catenin-activated cells.
Park S; Chun S
Biochim Biophys Acta; 2011 Dec; 1810(12):1340-5. PubMed ID: 21763403
[TBL] [Abstract][Full Text] [Related]
32. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
[TBL] [Abstract][Full Text] [Related]
33. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor.
Dong YF; Soung do Y; Schwarz EM; O'Keefe RJ; Drissi H
J Cell Physiol; 2006 Jul; 208(1):77-86. PubMed ID: 16575901
[TBL] [Abstract][Full Text] [Related]
34. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
35. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
[TBL] [Abstract][Full Text] [Related]
36. Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.
Nath N; Vassell R; Chattopadhyay M; Kogan M; Kashfi K
Biochem Pharmacol; 2009 Nov; 78(10):1298-304. PubMed ID: 19576865
[TBL] [Abstract][Full Text] [Related]
37. Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells.
Marchenko ND; Marchenko GN; Weinreb RN; Lindsey JD; Kyshtoobayeva A; Crawford HC; Strongin AY
Int J Biochem Cell Biol; 2004 May; 36(5):942-56. PubMed ID: 15006646
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway.
Wang Y; Zhou X; Zhu H; Liu S; Zhou C; Zhang G; Xue L; Lu N; Quan L; Bai J; Zhan Q; Xu N
Oncogene; 2005 Oct; 24(44):6637-45. PubMed ID: 16007168
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy approach in prostate cancer cells using an active Wnt signal.
Giladi N; Dvory-Sobol H; Sagiv E; Kazanov D; Liberman E; Arber N
Biomed Pharmacother; 2007 Oct; 61(9):527-30. PubMed ID: 17904788
[TBL] [Abstract][Full Text] [Related]
40. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
